BioNTech to SHUT Singapore mRNA Plant by 2027 as Sales Plummet
BioNTech is turning out the lights at the Singapore plant and planned regional headquarters it purchased from Novartis at the height of the COVID-19 outbreak, reflecting a sharp reversal in the mRNA specialist’s trajectory since the pandemic’s end. BioNTech announced …